ArticleWomen's health (London, England)
'Information is power': A qualitative exploration of co-producing education resources about cardiovascular disease in partnership with women living with lupus.
Article in Women's health (London, England). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Patient awareness and perception of cardiovascular risk in rheumatic and musculoskeletal diseases: results from an international survey.EULAR rheumatology open · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSystemic lupus erythematosus (SLE) is a chronic autoimmune condition impacting 1 in 2000 people. As 90% of SLE patients are women, and racialized populations experience significantly poorer outcomes, we characterize SLE as gendered, racialized, invisible and episodic. Further compounding these inequities is an elevated risk of cardiovascular disease (CVD) among this population. Crucially, there is a dearth of research evidence as well as public knowledge pertaining to its aetiology and manifestations in women. Indeed, CVD is a primary driver of morbidity and mortality in SLE. Despite calls for improved screening and awareness among this high-risk population, there is a lack of risk prediction tools and patient education resources specific to SLE.
objectivesThe objectives of this study were to co-create a lay language patient education resource in partnership with SLE knowledge users, as well as to obtain recommendations on the development of an associated future CVD risk prediction tool designed specifically for this population. DESIGN/
methodsSemi-structured in-depth interviews and a focus group were conducted with women who are SLE patients (
resultsParticipants were knowledgeable about SLE but less informed about the risks of CVD. Few recalled discussing CVD with physician(s), but most were aware of differences in symptoms among men and women. Participants responded positively to the education resource and provided recommendations to improve accessibility, inclusivity and impact for the target audience. Participants agreed that they would use the future SLE-CALCULATOR tool and advised on its design and usability.
conclusionsThese results underscore CVD as an urgent women's health issue and highlight the need for inclusive patient education about the risks of CVD in SLE. The resource discussed herein begins to fill that gap.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.